Showing results (351-360 of 429) with videos related to

Sort By:
Pageof 43
Metallomics : Integrated Biometal Science|April 20, 2021
Zinc stable isotopes in urine as diagnostic for cancer of secretory organsKathrin Schilling, Rebekah E T Moore, Kaj V Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
World Journal of Gastrointestinal Surgery|May 16, 2017
Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancerKathryn E Hitchcock, R Charles Nichols, Christopher G Morris, et al.
Physics in Medicine and Biology|May 11, 2012
Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapyKaiyumars Contractor, Amarnath Challapalli, Giampaolo Tomasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expressionKaiyumars Contractor, Amarnath Challapalli, Tara Barwick, et al.
Clinical Chemistry|December 13, 2016
Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast CancerKaren Page, David S Guttery, Daniel Fernandez-Garcia, et al.
International Journal of Particle Therapy|April 8, 2021
Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical ProstatectomyShivam M Kharod, Catherine E Mercado, Christopher G Morris, et al.
Journal of Neurointerventional Surgery|June 21, 2020
The WOVEN trial: Wingspan One-year Vascular Events and Neurologic OutcomesMichael J Alexander, Alois Zauner, Rishi Gupta, et al.
International Journal of Particle Therapy|December 4, 2020
Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 StudyShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.
Pageof 43